Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Moodys
Express Scripts
Merck
Boehringer Ingelheim
Harvard Business School

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Patent: 6,008,436

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,008,436
Title: Nematode-resistant transgenic plants
Abstract:Nematode-resistant transgenic plants are disclosed. The plants comprise plant cells containing a DNA construct comprising a transcription cassette, which construct comprises, in the 5\' to 3\' direction, a promoter operable in the plant cells, and a DNA comprising at least a portion of a DNA sequence encoding a nematode-inducible transmembrane pore protein in either the sense or antisense orientation. Intermediates for producing the same along with methods of making and using the same are also disclosed. In an alternate embodiment of the invention, the sense or antisense DNA is replaced with a DNA encoding an enzymatic RNA molecule directed against the mRNA transcript of a DNA sequence encoding a nematode-inducible transmembrane pore protein.
Inventor(s): Conkling; Mark A. (Fuquay-Varina, NC), Opperman; Charles H. (Raleigh, NC), Acedo; Gregoria N. (Durham, NC), Song; Wen (Raleigh, NC)
Assignee: North Carolina State University (Raleigh, NC)
Application Number:08/654,025
Patent Claims:see list of patent claims

Details for Patent 6,008,436

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04   Start Trial North Carolina State University (Raleigh, NC) 2013-01-21 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04   Start Trial North Carolina State University (Raleigh, NC) 2013-01-21 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial North Carolina State University (Raleigh, NC) 2013-01-21 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Johnson and Johnson
Dow
Colorcon
McKesson
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.